Related Experiment Videos
HLA antigens in inflammatory bowel disease
The Tohoku Journal of Experimental Medicine
|August 1, 1980
Summary
Human Leukocyte Antigen (HLA) B5 is more prevalent in ulcerative colitis patients, particularly those with extensive disease. HLA A3 also showed a high relative risk in ulcerative colitis patients.
Area of Science:
- Immunogenetics
- Gastroenterology
Background:
- Inflammatory bowel disease (IBD) encompasses ulcerative colitis (UC) and Crohn's disease (CD).
- Genetic factors, including Human Leukocyte Antigen (HLA) genes, are implicated in IBD pathogenesis.
Purpose of the Study:
- To investigate the association between specific HLA antigens and the susceptibility to ulcerative colitis and Crohn's disease in a Japanese population.
Main Methods:
- Human Leukocyte Antigen (HLA) typing was performed using the microdroplet lymphocyte cytotoxicity test.
- The study included 60 UC patients, 10 CD patients, and 120 healthy Japanese controls.
Main Results:
- HLA B5 was significantly increased in UC patients (62%) compared to controls (40%).
- HLA B5 prevalence was higher in UC patients with left-sided or total colitis (65%).
- HLA A3 showed the highest relative risk (R.R = 6.3) in UC patients, and HLA B7 incidence was decreased.
Conclusions:
- The findings suggest a genetic predisposition to ulcerative colitis associated with specific HLA antigens, particularly HLA B5 and A3.
- Further research with larger cohorts is warranted to confirm these associations, especially for Crohn's disease.